Comparative Pharmacology
Head-to-head clinical analysis: MEPERIDINE AND ATROPINE SULFATE versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MEPERIDINE AND ATROPINE SULFATE versus QOLIANA.
MEPERIDINE AND ATROPINE SULFATE vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Meperidine is a synthetic opioid agonist primarily at mu-opioid receptors, producing analgesia; atropine is a competitive antagonist of muscarinic acetylcholine receptors, reducing gastrointestinal motility and secretions.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
1-2 mL (meperidine 50 mg/mL + atropine 0.4 mg/mL) IM or IV push (over 2-3 minutes) every 3-4 hours as needed.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Meperidine: Terminal half-life 3-4 hours (normal renal function), prolonged in hepatic disease (up to 7-10 hours) and renal impairment (normeperidine accumulates). Atropine: Terminal half-life 2-4 hours.
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Meperidine: Renal excretion of unchanged drug (~5-10%) and metabolites, primarily normeperidine (active), with <5% biliary/fecal. Atropine: Renal excretion (~30-50% unchanged), remainder as metabolites, minimal biliary/fecal.
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist